Delivery Order SPE2DR25D1100-SPE2DR26FCZ2A
- Not listed
- The Defense Logistics Agency awarded a $1,369.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 ml suspension (250 ml) on October 30, 2025, with completion scheduled for October 31, 2025. This award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the order from its corporate office location at the same address. The...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,008.18 firm fixed-price delivery order on August 25, 2025, for Oxcarbazepine 300 mg/5 ml suspension in a 250 ml container. This is a non-set-aside contract with an ultimate completion date of August 26, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml quantities, with a ceiling value of $1,216.72 and a firm fixed price structure. The delivery order is scheduled for completion by September 22, 2025, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting...
- The Defense Logistics Agency awarded a $1,725.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), an anticonvulsant medication used to treat neurological conditions. The delivery order, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $2,427.33 to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine 300 mg/5 ml suspension in a 250 ml container. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by December 3, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,036.14 to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml quantities. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of June 18, 2025, to be performed at the vendor's facility in Conshohocken, Pennsylvania. Oxcarbazepine is a neurological medication commonly used to treat seizure disorders and neuropathic pain conditions,...
- On September 3, 2025, the Defense Logistics Agency awarded a delivery order valued at $3,791.77 to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml quantities. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This delivery...
- This delivery order, awarded September 18, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Oxcarbazepine 300 mg/5 ml suspension in a 250 ml quantity with a ceiling value of $1,125.28. The award is unset-aside and competitively awarded under a firm fixed price structure, with an ultimate completion date of September 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the...
- The Defense Logistics Agency awarded a $1,088 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), a neurological medication commonly used to treat seizure disorders and neuropathic pain. The contract, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-competitive set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $5,056.99 delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units). This competitively awarded, firm fixed-price contract carries an ultimate completion date of January 6, 2026, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCZ2ADelivery Order
The Defense Logistics Agency awarded a $5,033.86 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Oxcarbazepine 300 mg/5 ml Suspension in a 250 ml quantity. This is a firm fixed-price contract with an ultimate completion date of January 13, 2026, with performance to be conducted in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and runs through December 2026. This comprehensive contract vehicle enables AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs globally, covering specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains. The current order for Oxcarbazepine, an anticonvulsant medication commonly used in neurological treatment, demonstrates the company's ongoing role in fulfilling essential pharmaceutical needs for federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 1/11/26 |